Locally advanced pancreatic cancer.
نویسندگان
چکیده
Treatment of locally advanced pancreatic cancer is palliative, based on chemotherapy and according to response, chemoradiotherapy can be applied. The authors summarize three abstracts (#LBA146, #256 and #303) presented on the 2013 ASCO Gastrointestinal Cancers Symposium, which were focused on treatment of locally advanced pancreatic cancer. A discussion is presented about the different chemotherapy or chemoradiotherapy regimens, that move away from gemcitabine-based treatment, and the effort to find less toxic, but efficient therapeutic combinations.
منابع مشابه
Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer?
Treatment of locally advanced pancreatic cancer is challenging. Despite continuing research, effective treatments continue to be elusive with median survival of only 8-12 months. Treatment options for locally advanced pancreatic cancer include radiation therapy, concurrent chemoradiation or chemotherapy. It is felt that radiation therapy is a suboptimal treatment as most of patients will die of...
متن کاملUpdates in Locally Advanced Pancreatic Cancer
Author Title Number of patients Study type #4060 Heinemann et al. [1] Randomized phase II trial with an uPA inhibitor (WX-671) in patients with locally advanced nonmetastatic pancreatic cancer 95 Prospective Randomized; phase II #4058 Ioka et al. [7] A multicenter phase II trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer 61 Prospective Single arm; phase II
متن کاملCase report: Irreversible electroporation for locally advanced pancreatic cancer
INTRODUCTION For patients with pancreatic adenocarcinoma who are not candidates for surgical resection, long-term survival is poor, even with currently available systemic and radiation therapy options. However, for those with locally advanced disease who do not have distant metastasis, locoregional control of the tumor has the potential to improve long-term outcomes. A newly developed technolog...
متن کاملPositive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer.
BACKGROUND Peritoneal lavage cytology in the staging of pancreatic cancer is not widely used given improvements in computed tomography (CT). The aim of this study was to determine the utility of peritoneal lavage cytology in predicting survival in locally advanced pancreatic cancer. METHODS Between 2000 and 2008, 202 patients with biopsy-proven pancreatic cancer who were determined by pancrea...
متن کاملCapecitabine and Concurrent Radiation in Patients with Locally Advanced Irresectable Pancreatic Cancer
Pancreatic carcinoma is the fourth leading cause of death worldwide [21]. Despite certain advances in diagnosis, surgical procedures and chemotherapy, the prognosis of pancreatic cancer patients remains dismal [27]. Resection of the tumor at an early stage of the disease is the only curative treatment option. Unfortunately, as pancreatic cancer lacks early symptoms, less than 25% of patients un...
متن کاملDoes Ablation Technique Utilized in the Management of Unresectable Locally Advanced Pancreatic Adenocarcinoma?
Radiofrequency ablation in the management of advanced pancreatic cancer should be no longer utilized in patients with locally advanced or metastatic pancreatic adenocarcinoma.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- JOP : Journal of the pancreas
دوره 14 2 شماره
صفحات -
تاریخ انتشار 2013